We are live on ! Find out more
SFI

Susquehanna Fundamental Investments Portfolio holdings

AUM $2.67B
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+21.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.33B
AUM Growth
+$2.19B
Cap. Flow
+$2.21B
Cap. Flow %
50.99%
Top 10 Hldgs %
9.94%
Holding
1,042
New
377
Increased
333
Reduced
160
Closed
123

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$43.5M
2
WMT icon
Walmart Inc
WMT
+$42.1M
3
PCAR icon
PACCAR
PCAR
+$42M
4
CHRD icon
Chord Energy
CHRD
+$41.4M
5
ADBE icon
Adobe
ADBE
+$38.4M

Top Sells

Rank Stock Value
1
USB icon
US Bancorp
USB
+$30.3M
2
BA icon
Boeing
BA
+$29.4M
3
CF icon
CF Industries
CF
+$15M
4
EXAS
Exact Sciences
EXAS
+$12.9M
5
XEL icon
Xcel Energy
XEL
+$10.8M

Sector Composition

Rank Sector Weight
1 Industrials 17.38%
2 Technology 13.64%
3 Healthcare 13.3%
4 Financials 11.71%
5 Consumer Discretionary 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLE icon
926
Allegion
ALLE
$14.1B
-40,222
Closed -$5.42M
AMGN icon
927
Amgen
AMGN
$225B
-10,400
Closed -$2.96M
APLE icon
928
Apple Hospitality REIT
APLE
$3.71B
-16,955
Closed -$278K
ARCB icon
929
ArcBest
ARCB
$3.14B
-2,600
Closed -$371K
ARQT icon
930
Arcutis Biotherapeutics
ARQT
$3.3B
-120,493
Closed -$1.19M
ARWR icon
931
Arrowhead Research
ARWR
$12.3B
-128,083
Closed -$3.66M
AVDX
932
DELISTED
AvidXchange
AVDX
-140,527
Closed -$1.85M
AXTA icon
933
Axalta
AXTA
$7.98B
-112,562
Closed -$3.87M
BANC icon
934
Banc of California
BANC
$3.1B
-89,383
Closed -$1.36M
BDTX icon
935
Black Diamond Therapeutics
BDTX
$121M
-16,218
Closed -$82.2K
BGFV
936
DELISTED
Big 5 Sporting Goods
BGFV
-26,877
Closed -$94.6K
BHVN icon
937
Biohaven
BHVN
$2.17B
-39,344
Closed -$2.15M
BLND icon
938
Blend Labs
BLND
$331M
-28,937
Closed -$94K
BLMN icon
939
Bloomin' Brands
BLMN
$975M
-44,800
Closed -$1.28M
BV icon
940
BrightView Holdings
BV
$1.08B
-13,000
Closed -$155K
CDRE icon
941
Cadre Holdings
CDRE
$1.44B
-6,223
Closed -$225K
CLW icon
942
Clearwater Paper
CLW
$356M
-5,900
Closed -$258K
CMPR icon
943
Cimpress
CMPR
$2.4B
-3,080
Closed -$273K
CORT icon
944
Corcept Therapeutics
CORT
$12.1B
-14,740
Closed -$371K
CP icon
945
Canadian Pacific Kansas City
CP
$81.5B
-106,800
Closed -$9.42M
CRSP icon
946
CRISPR Therapeutics
CRSP
$5.22B
-23,503
Closed -$1.6M
CXM icon
947
Sprinklr
CXM
$1.58B
-13,563
Closed -$166K
DBI icon
948
Designer Brands
DBI
$311M
-64,101
Closed -$701K
DHR icon
949
Danaher
DHR
$145B
-16,442
Closed -$4.11M
DHT icon
950
DHT Holdings
DHT
$3.01B
-12,562
Closed -$144K

Similar funds

Susquehanna Fundamental Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Susquehanna Fundamental Investments held 1,042 positions worth $4.33B, up 102% from $2.14B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Susquehanna Fundamental Investments deployed $2.21B of net new capital in Q2 2024, opening 377 new positions and adding to 333 existing holdings. Its largest new stake was Bristol-Myers Squibb: 972,243 shares worth $40.4M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Boeing, an estimated $29.4M trimmed.

  • Susquehanna Fundamental Investments's largest Q2 2024 buy was Bristol-Myers Squibb: 972,243 shares worth $40.4M.
  • Susquehanna Fundamental Investments added most to Chord Energy in Q2 2024, an estimated $41.4M increase.
  • Susquehanna Fundamental Investments's biggest Q2 2024 reduction was Boeing, cutting an estimated $29.4M.
  • Susquehanna Fundamental Investments fully exited US Bancorp in Q2 2024, selling an estimated $30.3M.
  • Susquehanna Fundamental Investments's ten largest holdings make up 9.9% of its $4.33B portfolio in Q2 2024.
  • Susquehanna Fundamental Investments opened 377 new positions and closed 123 in Q2 2024.
  • Susquehanna Fundamental Investments's portfolio value rose 102% quarter-over-quarter to $4.33B.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2024, filed 15 Aug 2024.